SELLAS Life Sciences Group, Inc. Income Statement

Income Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.53M1.90M7.60M1.00M
Cost of Revenue 0.20M0.10M
Gross Profit -0.53M1.90M7.40M0.90M
Operating items
Research & Development 7.87M3.85M14.61M11.39M7.29M9.28M15.67M20.27M24.01M
Selling, General & Administrative 8.75M8.63M6.58M4.59M9.92M9.60M11.32M12.58M13.86M
Other Operating Expenses -4.70M28.39M2.83M5.90M10.10M
Operating Expenses 16.62M12.49M21.20M15.99M20.04M18.88M32.89M42.95M37.87M
Operating Income -3.90M-11.69M-15.99M-20.04M-16.98M-25.29M-41.95M-37.87M
EBIT -11.99M-3.90M-11.69M-15.99M-20.04M-16.98M-25.29M-41.95M-37.87M
Non-operating items
Interest & Investment Income 0.01M-0.01M-0.03M
Other Non Operating Income 4.63M9.09M-13.14M0.67M0.21M
Non Operating Income 4.63M9.09M-13.18M0.21M4.36M0.65M0.53M
Net income details
EBT -11.99M-3.41M-34.38M-16.51M-19.37M-16.77M-20.94M-41.30M-37.87M
Tax Provisions -1.05M0.04M-0.08M-0.02M-0.24M
Profit After Tax -11.99M-11.48M-34.97M-17.68M-19.29M-16.76M-20.70M-41.30M-37.34M
Income from Continuing Operations -11.99M-3.41M-33.33M-16.56M-19.29M-16.76M-20.70M-41.30M-37.87M
Consolidated Net Income -11.99M-8.08M-1.64M-16.56M-19.29M-16.76M-20.70M-41.30M-37.87M
Income towards Parent Company -11.99M-8.08M-1.64M-16.56M-19.29M-16.76M-20.70M-41.30M-37.87M
Preferred Dividend Payments 8.42M0.08M
Net Income towards Common Stockholders -11.99M-8.08M-1.64M-17.68M-27.95M-16.84M-20.70M-41.30M-37.87M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.03M0.44M4.87M15.08M15.91M20.59M32.06M70.38M
Shares Outstanding (Diluted Average) 7.98M15.48M19.40M27.78M
EBITDA -11.99M-3.90M-11.69M-15.99M-20.04M-16.98M-25.29M-41.95M-37.87M
Tax Rate 3.06%0.42%0.10%1.13%